Serum Institute of India CEO Adar Poonawalla struck a deal on Tuesday to pick up a defunct Czech outfit for €72 million.

Swedish CDMO Recipharm’s growing global footprint in 2016 has positioned the company to take advantage of what is expected to be more consolidation and growth…

The race to snatch up generics maker Stada is heating up—and fast—with multiple players reportedly preparing to jump in, including Chinese drugmakers and,…

Sun Pharma has snapped up Ocular Technologies from Auven Therapeutics, adding to its growing eyecare medicines pipeline.

More than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a…

Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.

With Mitsubishi Tanabe deal, Sun Pharma takes a basket of new meds into Japan, a market where Indian drugmakers are under-represented.

"Binding" $1 billion offers are said to be on the table as Indian drugmakers Aurobindo and Intas go head-to-head for Teva's generics business in…